Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1263-73. doi: 10.1152/ajpheart.00152.2009. Epub 2009 Aug 21.

Abstract

To define the necessity of calcineurin (Cn) signaling for cardiac maturation and function, the postnatal phenotype of mice with cardiac-specific targeted ablation of the Cn B1 regulatory subunit (Ppp3r1) gene (csCnb1(-/-) mice) was characterized. csCnb1(-/-) mice develop a lethal cardiomyopathy, characterized by impaired postnatal growth of the heart and combined systolic and diastolic relaxation abnormalities, despite a lack of structural derangements. Notably, the csCnb1(-/-) hearts did not exhibit diastolic dilatation, despite the severe functional phenotype. Myocytes isolated from the mutant mice exhibited reduced rates of contraction/relaxation and abnormalities in calcium transients, consistent with altered sarcoplasmic reticulum loading. Levels of sarco(endo) plasmic reticulum Ca-ATPase 2a (Atp2a2) and phospholamban were normal, but phospholamban phosphorylation was markedly reduced at Ser(16) and Thr(17). In addition, levels of the Na/Ca exchanger (Slc8a1) were modestly reduced. These results define a novel mouse model of cardiac-specific Cn deficiency and demonstrate novel links between Cn signaling, postnatal growth of the heart, pathological ventricular remodeling, and excitation-contraction coupling.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aging / metabolism
  • Animals
  • Calcineurin / deficiency*
  • Calcineurin / genetics
  • Calcium Signaling* / genetics
  • Calcium-Binding Proteins / metabolism
  • Cardiomyopathies / genetics
  • Cardiomyopathies / metabolism*
  • Cardiomyopathies / pathology
  • Cardiomyopathies / physiopathology
  • Cardiotonic Agents / administration & dosage
  • Dobutamine / administration & dosage
  • Fatty Acids / metabolism
  • Genotype
  • Heart Ventricles / metabolism
  • Heart Ventricles / physiopathology
  • Intracellular Signaling Peptides and Proteins / deficiency*
  • Intracellular Signaling Peptides and Proteins / genetics
  • Male
  • Mice
  • Mice, Knockout
  • Mitochondria, Heart / metabolism
  • Muscle Proteins / deficiency*
  • Muscle Proteins / genetics
  • Myocardial Contraction* / drug effects
  • Myocardial Contraction* / genetics
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Oxidation-Reduction
  • Phenotype
  • Phosphorylation
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
  • Serine
  • Sodium-Calcium Exchanger / metabolism
  • Threonine
  • Ventricular Dysfunction, Left / genetics
  • Ventricular Dysfunction, Left / metabolism*
  • Ventricular Dysfunction, Left / pathology
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Remodeling

Substances

  • Calcium-Binding Proteins
  • Cardiotonic Agents
  • DSCR1 protein, mouse
  • Fatty Acids
  • Intracellular Signaling Peptides and Proteins
  • Muscle Proteins
  • Sodium-Calcium Exchanger
  • phospholamban
  • sodium-calcium exchanger 1
  • Threonine
  • Dobutamine
  • Serine
  • Calcineurin
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Atp2a2 protein, mouse